Wright Medical boosts foot and ankle footprint with BioMimetic buy

11/20/2012 | American City Business Journals

Wright Medical has agreed to acquire BioMimetic Therapeutics for $190 million upfront, plus as much as $190 million in payments contingent on the performance of BioMimetic's Augment bone graft tool. The deal, set to be finalized during the first quarter of next year, in part will allow Wright Medical to substantially expand its foot and ankle business, CEO Robert Palmisano said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY